Grünenthal Meds
0 followers
Grünenthal Meds was established in August 2023, as part of a Joint Venture Collaboration between Grünenthal and Kyowa Kirin. Headquartered in the UK, we are responsible for managing a portfolio of 13 medicines across six key therapeutic areas, including cancer pain, constipation, and bone health. T... Read more
Org chart
Christoph Stolle
Chief Executive Officer
Christoph Stolle
Collapse
Rob May
Vp, Head Of Business Development And Partner Business
Chris Fuller
Regional Brands Director (emea)
Dave Biddles
Sales And Marketing Lead
Alan King
Chief Financial Officer
Michael Kells
Vp, Head Of Medical
Ian Povall
Head Of Commercial Operations Uk&i
Lesley Carlyle
Head Of Compliance
Paula Alfaro Chacón
Team Assistant
